Tag: drugs

Healthcare providers express cash flow concerns under new 340B rebate model

Editor's Note Healthcare providers could experience significant cash flow and operational changes under a new voluntary pilot program that fundamentally alters how the nation's second-largest drug payment program operates, according to an August 11 article in Modern Healthcare. As detailed in the article, The Health Resources and Services Administration announced…

Read More

By: Matt Danford
August 12, 2025
Share

FDA orders opioid label changes to highlight long-term risks

Editor's Note The US Food and Drug Administration (FDA) is requiring safety labeling changes for all opioid pain medications to better emphasize and explain the risks associated with long-term use, according to a July 31 announcement. These changes follow a May advisory committee meeting where the agency reviewed data on…

Read More

By: Matt Danford
August 6, 2025
Share

GLP-1 drugs show promise for preoperative weight loss

Editor's Note Glucagon-like peptide-1 (GLP-1) receptor agonists may offer orthopedic patients with obesity and type 2 diabetes a powerful tool for preoperative weight loss and potential disease modification, according to a July 10 review article in The Journal of Bone and Joint Surgery. However, the agents carry perioperative risks that…

Read More

By: Matt Danford
July 28, 2025
Share

Preoperative, postoperative GLP-1s improve weight loss in bariatric surgery patients

Editor's Note Research shows using GLP-1 receptor agonists both before and after bariatric surgery is associated with greater total weight loss than surgery alone, according to a July 13 article in MedPage Today. The article focuses on a retrospective analysis of 568 patients presented at ENDO 2025, the annual meeting…

Read More

By: Matt Danford
July 18, 2025
Share

CMS proposes 2026 Medicare pay bump, targets wasteful spending

Editor's Note The Centers for Medicare & Medicaid Services (CMS) has proposed a 3.62% increase to the 2026 Medicare physician fee schedule, according to a July 14 article in Fierce Healthcare. The proposed rule sets the conversion factor at $33.42, up from $32.35 in 2025. The increase reflects a 2.5%…

Read More

By: Matt Danford
July 15, 2025
Share

Study: Stem cell strategy could eliminate kidney transplant patients’ need for immunosuppressants

Editor's Note A stem cell-based transplant method enabled most kidney recipients in a recent clinical trial to stop taking immunosuppressive drugs, according to a July 15 article in HealthDay. As detailed in the article, the approach was tested in a phase 3 multicenter, randomized controlled trial published in the American…

Read More

By: Matt Danford
July 15, 2025
Share

Study: Feedback-based intervention boosts opioid prescribing adherence without worsening pain control

Editor's Note Providing tailored feedback to surgical prescribers significantly increased adherence to opioid prescribing guidelines without affecting patients’ ability to manage postoperative pain, according to research published June 11 in JAMA Surgery.  The study tested whether monthly reports that included peer prescribing comparisons and patient-reported outcomes could influence opioid prescribing…

Read More

By: Matt Danford
July 10, 2025
Share

FDA inspections slow as support staff layoffs strain overseas oversight

Editor's Note Logistical staff layoffs at the US Food and Drug Administration (FDA) are hindering the agency’s ability to scrutinize drug manufacturing safety in foreign countries, according to a July 7 report in ProPublica. A spokesperson from the US Department of Health and Human Services (HHS) told ProPublica that FDA…

Read More

By: Matt Danford
July 8, 2025
Share

Study: Racial, insurance disparities persist in access to buprenorphine after opioid-related events

JAMA (healthcare publication) Network logo

Editor's Note Black and Hispanic patients remain significantly less likely than White patients to receive buprenorphine after an opioid-related health care event, according research published June 26 in JAMA Network Open. Patients with Medicaid or Medicare Advantage also had higher odds of receiving buprenorphine than those with commercial insurance. The…

Read More

By: Matt Danford
July 2, 2025
Share

Study: Preoperative dexmedetomidine stabilizes vitals in anxious GI cancer patients

Editor's Note Low-dose dexmedetomidine effectively stabilizes blood pressure and heart rate during key perioperative stages in gastrointestinal tumor patients with moderate to severe anxiety, according to a July 1 study published in BMC Psychiatry.   Researchers enrolled 100 patients undergoing elective laparoscopic gastrointestinal tumor resection. Anxiety levels were measured using…

Read More

By: Matt Danford
July 1, 2025
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat